Ä¢¹½¶ÌÊÓƵ

The U.S. Food and Drug Administration is reviewing the safety and efficacy of mifepristone, a drug used widely in medical abortions. The review has raised concerns about potential new restrictions on access to abortion in the United States. 

Christopher Labos, MD, is an Associate at Ä¢¹½¶ÌÊÓƵ’s Office for Science and Society. He can discuss the known evidence on mifepristone and the broader implications of the review. 

christopher.labos [at] mcgill.ca (English, French)